Antiangiogenic effects of recombinant human endostatin in lung cancers.

about

Antiangiogenic effects of recombinant human endostatin in lung cancers.

Item

http://www.wikidata.org/entity/Q47370386

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

Antiangiogenic effects of recombinant human endostatin in lung cancers.

@en

Antiangiogenic effects of recombinant human endostatin in lung cancers.

@nl

type

Item

label

Antiangiogenic effects of recombinant human endostatin in lung cancers.

@en

Antiangiogenic effects of recombinant human endostatin in lung cancers.

@nl

prefLabel

Antiangiogenic effects of recombinant human endostatin in lung cancers.

@en

Antiangiogenic effects of recombinant human endostatin in lung cancers.

@nl

P1476

Antiangiogenic effects of recombinant human endostatin in lung cancers

@en

P2093

Chaofen Zhao

http://www.w3.org/2001/XMLSchema#string

Dandan Cui

http://www.w3.org/2001/XMLSchema#string

Guocheng Du

http://www.w3.org/2001/XMLSchema#string

Hong Chen

http://www.w3.org/2001/XMLSchema#string

Lang He

http://www.w3.org/2001/XMLSchema#string

Lina Tang

http://www.w3.org/2001/XMLSchema#string

Shimin Wen

http://www.w3.org/2001/XMLSchema#string

Xun Wu

http://www.w3.org/2001/XMLSchema#string

Yunxiang Li

http://www.w3.org/2001/XMLSchema#string

P2860

Endostatin: an endogenous inhibitor of angiogenesis and tumor growth

Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT Method

Effects of recombinant human endostatin and its synergy with cisplatin on circulating endothelial cells and tumor vascular normalization in A549 xenograft murine model.

Recombinant human endostatin normalizes tumor vasculature and enhances radiation response in xenografted human nasopharyngeal carcinoma models.

Normalizing tumor vasculature with anti-angiogenic therapy: a new paradigm for combination therapy.

Tumor hypoxia at the micro-regional level: clinical relevance and predictive value of exogenous and endogenous hypoxic cell markers.

Regulator of G-protein signaling 5 (RGS5) protein: a novel marker of cancer vasculature elicited and sustained by the tumor's proangiogenic microenvironment.

Recombinant human endostatin enhances the radioresponse in esophageal squamous cell carcinoma by normalizing tumor vasculature and reducing hypoxia

A phase II, randomized, double-blind, placebo-controlled multicenter trial of Endostar in patients with metastatic melanoma.

Solid tumor physiology and hypoxia-induced chemo/radio-resistance: novel strategy for cancer therapy: nitric oxide donor as a therapeutic enhancer.

P304

79-86

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3892/MMR.2017.7859

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Kang Liu

P577

2017-10-24T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29115591

http://www.w3.org/2001/XMLSchema#string

P932

5780156

http://www.w3.org/2001/XMLSchema#string